sec filing
PA
NASDAQ · PASG
Passage Bio, Inc.
Healthcare · Biotechnology
$3.45
Down-$0.07 (-1.99%)
Updated Nov 1, 2026, 9:21 PM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 33.12M
- P/E ratio
- -0.58
- Dividend yield
- 0.00%
- 52-week range
- $3.29 – $12.05
- Volume
- 7.17K
- Avg. volume
- 41.46K
Price performance · PASG
PASG price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
PASG closed at $3.45 after 20 trading sessions, down 15.65% for the selected period.
- Last close
- $3.45
- Period change
- -15.65%
- Period low
- $3.33
- Period high
- $4.55
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.48 | $3.605 | $3.44 | $3.45 | 7.17K |
| Oct 29, 2026 | $3.33 | $3.83 | $3.33 | $3.52 | 16.69K |
| Oct 28, 2026 | $3.30 | $3.565 | $3.30 | $3.33 | 8.03K |
| Oct 27, 2026 | $3.31 | $3.40 | $3.31 | $3.35 | 3.99K |
| Oct 26, 2026 | $3.365 | $3.365 | $3.3589 | $3.3589 | 1.63K |
| Oct 23, 2026 | $3.63 | $3.63 | $3.345 | $3.37 | 21.54K |
| Oct 22, 2026 | $3.4217 | $3.86 | $3.4217 | $3.51 | 43.94K |
| Oct 21, 2026 | $3.56 | $3.59 | $3.47 | $3.59 | 2.91K |
| Oct 20, 2026 | $3.4537 | $3.68 | $3.4537 | $3.60 | 5.66K |
| Oct 19, 2026 | $3.50 | $3.60 | $3.43 | $3.58 | 10.9K |
| Oct 16, 2026 | $3.61 | $3.76 | $3.37 | $3.50 | 16.8K |
| Oct 15, 2026 | $3.60 | $3.92 | $3.60 | $3.60 | 15.94K |
| Oct 14, 2026 | $3.64 | $3.93 | $3.62 | $3.66 | 7.84K |
| Oct 13, 2026 | $4.46 | $4.46 | $3.63 | $3.64 | 14.22K |
| Oct 12, 2026 | $3.61 | $4.55 | $3.60 | $4.55 | 76.4K |
| Oct 9, 2026 | $3.83 | $3.83 | $3.61 | $3.69 | 12.11K |
| Oct 8, 2026 | $3.77 | $3.83 | $3.62 | $3.78 | 15.79K |
| Oct 7, 2026 | $4.00 | $4.05 | $3.7625 | $3.855 | 14.06K |
| Oct 6, 2026 | $4.13 | $4.2899 | $4.08 | $4.08 | 6.57K |
| Oct 5, 2026 | $4.05 | $4.19 | $4.05 | $4.09 | 17.93K |
Latest PASG news
The latest Smart Investors Daily articles mentioning PASG.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…